+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Neurofibromatosis Type 1 - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibromatosis Type 1 - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2025 - Product Thumbnail Image

Neuromyelitis Optica Spectrum Disorder (NMOSD) - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Thyroid Eye Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Thyroid Eye Disease - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Androgen Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Androgen Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Schnitzler Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Schnitzler Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Formyl Peptide Receptor - Pipeline Insight, 2025 - Product Thumbnail Image

Formyl Peptide Receptor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Food Allergies - Pipeline Insight, 2025 - Product Thumbnail Image

Food Allergies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complex Regional Pain Syndromes- Pipeline Insight, 2025 - Product Thumbnail Image

Complex Regional Pain Syndromes- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TRPV1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

TRPV1 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
IgE Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

IgE Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Apolipoprotein C-III Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Apolipoprotein C-III Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Factor XI Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Factor XI Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neonatal Fc Receptor Antagonists- Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Fc Receptor Antagonists- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complement C1s Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1s Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complement C3 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C3 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more